Impact of COVID-19 on cancer patients: A review.
Iago Dillion Lima CavalcantiJosé Cleberson Santos SoaresPublished in: Asia-Pacific journal of clinical oncology (2020)
To inform about the impact of COVID-19 on cancer patients, a literature review was carried out, using the descriptors "COVID-19," "SARS-CoV-2," "Oncology," and "Coronavirus," in the Pubmed, Sciencedirect, and Scifinder databases. Fifty-three articles were included after analyzing the inclusion and exclusion criteria, being divided into five sessions: Epidemiological aspects of COVID-19; Pathophysiology of COVID-19; Clinical aspects of cancer patients; Risks to cancer patients infected with COVID-19; and Care for cancer patients amid a pandemic. The cancer patient has a weakened immune system, due to characteristics specific to the development of cancer or even chemotherapy, leaving these patients more susceptible to infections by COVID-19. Thus, the development of protection plans for cancer patients should be encouraged, reducing the exposure of these patients to the SARS-CoV-2 virus, contributing to the maintenance of the health of the cancer patient, and avoiding possible therapeutic complications that can lead the patient to death.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- end stage renal disease
- case report
- papillary thyroid
- ejection fraction
- healthcare
- newly diagnosed
- chronic kidney disease
- public health
- palliative care
- squamous cell carcinoma
- machine learning
- mental health
- peritoneal dialysis
- patient reported outcomes
- risk assessment
- risk factors
- artificial intelligence
- deep learning
- chronic pain
- human health